Ryman rights trading ends on a sour note

Ryman rights trading ends on a sour note
Salt Funds' Matt Goodson said time will tell whether Ryman shares are cheap. (Image: Salt Funds)
Jenny Ruth
Ryman Healthcare’s $902 million rights issue is drawing to a dismal close, with the price of the rights falling as low as 7.5 cents on Tuesday, the last day of trading.Two weeks ago, in the institutional book-build auction process, institutional investors were prepared to pay an effective $1 for the rights.You could say that was a little disappointing because the theoretical value of the rights price was $1.03 – institutions paid $6 for the shares issued at $5, so the additional price paid reflected the value they put on the rights....

More Finance

Wisdom from Milford’s ‘oldest’ fund manager
Finance

Wisdom from Milford’s ‘oldest’ fund manager

Stephen Johnston has been watching markets since 1997.

Gregor Thompson 09 Jan 2025
RBNZ issues first non-bank deposit-taker licence in nearly a decade
Finance

RBNZ issues first non-bank deposit-taker licence in nearly a decade

The Reserve Bank of New Zealand has issued a non-bank deposit taker licence to newly formed finance company Welcome.The last time the central bank issued a license was in 2017 to Christian Savings, which was previously licensed as Christian Savings Incorporated, according to the...

Staff reporters 08 Jan 2025
How tax rules discourage wealthy investor migrants
Finance

How tax rules discourage wealthy investor migrants

Covid refugees facing a four-year time limit on tax status are forcing the issue.

Pattrick Smellie 06 Jan 2025
M&A outlook: get set for big ticket IPOs
Finance

M&A outlook: get set for big ticket IPOs

Experts are picking a surge in mergers and acquisitions activity for 2025.